Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Addiction to methamphetamine is a serious health problem in the United States. Right now,
there are no medications that a doctor can give someone to help them stop using
methamphetamine. More research is needed to develop drugs for methamphetamine addiction.
Ibudilast (the study drug) is a drug that could help people addicted to methamphetamine.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University VA Office of Research and Development
Collaborators:
Oregon Health and Science University Portland VA Medical Center